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Abstract We investigated whether low-intensity pulsed
ultrasound (LIPUS) stimulates chondrocyte proliferation
and matrix production in explants of human articular
cartilage obtained from donors suffering from unicomparti-
mental osteoarthritis of the knee, as well as in isolated human
chondrocytes in vitro. Chondrocytes and explants were
exposed to LIPUS (30 mW/cm2; 20 min/day, 6 days).
Stimulation of [35S]-sulphate incorporation into proteogly-
cans by LIPUS was 1.3-fold higher in degenerative than in
collateral monolayers as assessed biochemically and
1.9-fold higher in explants as assessed by autoradiography.
LIPUS decreased the number of cell nests containing 1–3
chondrocytes by 1.5 fold in collateral and by 1.6 fold in
degenerative explants. LIPUS increased the number of nests
containing 4–6 chondrocytes by 4.8 fold in collateral and by
3.9 fold in degenerative explants. This suggests that LIPUS
stimulates chondrocyte proliferation and matrix production
in chondrocytes of human articular cartilage in vitro. LIPUS
might provide a feasible tool for cartilage tissue repair in
osteoarthritic patients, since it stimulates chondrocyte pro-
liferation and matrix production.
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1 Introduction
Articular cartilage has a very limited capacity for self-
repair [6]. Traumatic chondral lesions often result in
chronic degeneration in the long run, and eventually
osteoarthritis (OA) can develop [6]. The long-term prog-
nosis of these chondral lesions is of eminent importance,
especially in adults aged less than 50 years, since arthro-
plasty is not an option to consider at younger age. These
patients will likely benefit from a treatment that improves
the repair of chondral tissue. Such a treatment could
postpone the need for surgical treatment or even make
surgical treatment in a later stage unnecessary.
Low-intensity pulsed ultrasound (LIPUS) has been
shown to stimulate osteogenesis and fracture healing [5, 6,
11, 14, 15, 18, 19]. LIPUS not only stimulates bone for-
mation in vitro as well as in vivo [5, 10, 11, 14, 15, 18], but
it also exerts anabolic effects on cartilage formation [2, 13,
16, 17, 20–22]. The stimulatory effect of LIPUS on
chondrocytes and cartilage matrix production in fractured
bone results in stimulation of the healing process and
improves the repair of chondral tissue [2, 12, 16, 17, 20].
LIPUS has been reported to stimulate rat chondrocyte
proliferation and matrix production in vitro, suggesting an
overall anabolic effect on cartilage formation [16, 17, 20].
LIPUS also stimulated the healing of osteochondral defects
in rabbit knees in vivo [2]. Whether LIPUS also exerts an
anabolic effect on human osteoarthritic or non-osteoarthritc
chondrocyte proliferation and cartilage matrix production
is as yet unknown. Therefore, we investigated whether
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LIPUS stimulates proliferation and matrix production of
chondrocytes in explants from human articular cartilage,
obtained from the degenerative compartment and the
collateral compartment from donors suffering from uni-
compartimental OA of the knee, as well as in isolated
human chondrocytes in vitro.
2 Materials and methods
2.1 Culture of chondrocytes
Human articular cartilage samples (surgical waste) were
harvested during total knee arthroplasty from two male
donors, aged 69 and 71 years, suffering from unicom-
partimental OA of the knee. The protocol was approved
by the Ethical Review Board of the Vrije Universiteit
Medical Center. The cells of the collateral compartment
of one donor are the controls for the cells of the
degenerative compartment of the same donor. Therefore,
this is a within donor-controlled study. The cartilage
from the degenerative compartment and the collateral
compartment were kept separately. The articular cartilage
was kept under sterile conditions in phosphate buffered
saline (PBS) for maximally 3 h, until it was separated
from the underlying bone. Successively the cartilage was
morsalized to roughly 1 mm pieces and incubated with
2 mg/ml collagenase II (Worthington, Freehold, NJ,
USA) in Dulbecco’s Modified Eagle Medium (DMEM,
Gibco, Paisley, UK) for 2 h at 37C. The released
chondrocytes were cultured in six-well culture plates
(Costar, Cambridge, MA, USA) at 25 9 103 cells/well
with 2.54 ml of fluid medium per well. One culture plate
per donor was used for chondrocytes obtained from the
degenerative knee compartment, and one plate per donor
for chondrocytes obtained from the collateral compart-
ment. In total, four culture plates were collected for this
study. The culture medium consisted of DMEM (Gibco)
without nucleosides, supplemented with 10% fetal bovine
serum (FBS, Hyclone, Logan, UT, USA), 0.6 mM L(?)
ascorbic acid (Merck, Darmstadt, Germany), 1.25 lg/ml
fungizone (Gibco), 50 lg/ml gentamycin (Gibco), 100 U/
ml penicillin (Sigma, St Louis, MO, USA) and 50 lg/ml
streptomycin sulphate (Sigma). Culture medium was
changed twice per week and before the start of LIPUS
treatment. Before [35S]-sulphate labeling as described
below, the medium was replaced as well. The culture
plates were placed in a 37C incubator containing a
humidified atmosphere with 5% CO2 in air and cultured
for 7 days to allow formation of chondrocyte monolayer
cultures. LIPUS treatment was started after 7 days of
pre-culture, as described below.
2.2 Culture of cartilage explants
An explant model was used, in which the chondrocytes
reside within their natural environment, surrounded by
their own matrix. By using this in vitro explant model, we
aimed to mimic the in vivo situation as closely as possible.
Full thickness cartilage samples (surgical waste) were
taken from 4 donors, 1 male and 3 females, age 61–
72 years, with unicompartimental OA of the knee. The
protocol was approved by the Ethical Review Board of the
Vrije Universiteit Medical Center. The explants of the
collateral compartment of one donor are the controls for the
explants of the degenerative compartment of the same
donor. Therefore, this is a within donor-controlled study.
Articular cartilage was collected from harvested waste
material during total knee arthroplasty from the degener-
ative as well as from the collateral compartment. At the day
of surgery, cylindrical full thickness cartilage explants
were taken from the weight-bearing surface, by using an
10 cm 11 gauge diameter biopsy needle (Osteo-Site Bone
Biopsy Needle, Cook Medical Inc., Bloomington, IL,
USA). The cartilage explants were kept under sterile con-
ditions in PBS, which was replaced by culture medium
within 3 h.
The explants were separated from the underlying bone
and cultured in six-well culture plates (Costar) in
2.54 ml of fluid medium per well, with one explant per
well. The medium consisted of DMEM (Gibco) without
nucleosides, supplemented with 10% FBS (Hyclone),
0.6 mM L(?) ascorbic acid (Merck), 1.25 lg/ml fungi-
zone (Gibco), 50 lg/ml gentamycin (Gibco), 100 U/ml
penicillin (Sigma) and 50 lg/ml streptomycin sulphate
(Sigma). Culture medium was changed twice per week
and before the start of LIPUS treatment. Before [35S]-
sulphate labeling as described below, the medium was
replaced as well. The explant cultures were placed in a
37C incubator containing a humidified atmosphere with
5% CO2 in air and cultured. LIPUS treatment was
started after 24 h of preculture, as described below.
2.3 Low intensity pulsed ultrasound (LIPUS) treatment
LIPUS treatment was started after 7 days of pre-culture for
the monolayer cultures, and after 24 h of pre-culture for the
cartilage explants. Half of the degenerative chondrocyte
monolayers and cartilage explant cultures and half of the
collateral chondrocyte monolayers and cartilage explant
cultures in the six-well culture plates were exposed to LI-
PUS (30 mW/cm2) during 20 min per day for a period of
6 days. The other half of the cultures served as non-treated
controls. The therapy unit consisted of two sonic acceler-
ated fracture healing system devices (SAFHS, model 2A;
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Exogen, Smith & Nephew Inc., Memphis, TN, USA) and
three transducers per device, which were connected by
coupling gel to the six-well culture plate. The wells were
filled with 2.54 ml standardized fluid culture medium to
achieve a liquid-height equivalent to one quarter of the
carrier frequency wavelength [15]. The SAFHS device
provides low-intensity ultrasound at 1.5 MHz frequency.
This setting was used in earlier experiments by Smith and
Nephew Inc. and has proven to provide ultrasonic waves in
the medium [15]. The distance between the transducer and
the cultures was less than 2 mm. Control culture plates
were kept under identical conditions in six well plates, but
were not exposed to LIPUS treatment.
2.4 [35S]-Labeling and biochemical analysis
To assess cartilage formation biochemically, [35S]-sul-
phate incorporation into proteoglycans was measured.
The monolayers and the explant cultures were labeled
with [35S]-sulphate by pulsing with 10 ll and 20 ll
Na2
35SO4 (specific activity 1000 Ci/mMole; Radiochem-
ical Centre, Amersham, UK) for the last 24 h of culture.
After removal of the medium, the monolayer cultures
were rinsed extensively with PBS to remove exchange-
able radioactivity [8], and incubated for 1 h with 0.5 M
NaOH. The explants were rinsed three times extensively
with PBS to remove exchangeable radioactivity [8], and
0.5 ml 6 M HCl was added. The [35S]-sulphate incor-
poration into proteoglycans was quantified by liquid
scintillation counting (LKB—Wallac, Rockville, MD,
USA).
To normalize [35S]-sulphate incorporation for the
monolayer cultures, the DNA content was determined by
using CyQuant cell proliferation assay kit (C-7026)
(Molecular Probes, Invitrogen, Carlsbad, CA, USA). DNA
content was quantified by measuring fluorescence at
520 nm using a Fluostar Galaxy spectrophotometer (BMG
labtechnologies, Offenburg, Germany). Since the matrix
components of the explants interfere with the DNA mea-
surements, the [35S]-sulphate incorporation was expressed
per milligram dry weight.
2.5 Autoradiography
Autoradiography was performed on 16 explants. After
[35S]-sulphate labeling of proteoglycans, the cultured
explants were fixed in 4% phosphate-buffered formalde-
hyde (Merck) overnight at 4C, and subsequently
embedded in glycol methacrylate (GMA). For every
explant, three undecalcified sections of 5 lm thickness in
the center of the explant were cut by a heavy duty
microtome (Jung-K, R. Jung, Heidelberg, Germany). The
distance between the three sections was 10 lm.
[35S]-Sulphate incorporation in the matrix by chondro-
cytes was analysed by autoradiography performed with
Ilford Nuclear Emulsion (Ilford, Essex, UK). The expo-
sure time was 3.5 weeks, as determined by the amount
of [35S]-sulphate incorporated. The sections were coun-
terstained with toluidine blue. [35S]-Sulphate
incorporation was assessed by counting the number of
dots per cell in the complete microscopic field. This is
indicative for the amount of [35S]-sulphate incorporated
into proteoglycans during cartilage matrix production.
2.6 Histology
The cartilage explants that were not labeled with [35S]-
sulphate were used for histology. After fixation in 10%
phosphate-buffered formalin overnight at 4C, the sam-
ples were embedded in methylmetacrylate (MMA).
Undecalcified sections of 5 lm thickness were cut by a
heavy duty microtome (Jung-K). Sections were stained
with 0.1% toluidin blue for light microscopy and histo-
morphometry. To monitor proliferation in the center of
the explants, the number of cell nests and the size of the
cell nests were assessed at two locations: (1) in the
superficial layer, which is the layer closest to the joint,
and (2) in the deep layer, which is the layer closest to
the bone.
2.7 Statistical methods
A power analysis for the number of cultures and for the
number of explants was conducted to calculate the sample
size needed. Using a two-sided significance level of 5%
and a power of 60% a sample size of n = 6 per group is
sufficient to be able to detect an effect size of d = 1.40
[d = (mean1 - mean2/SD)] [1].
Data are expressed as mean ± SEM. Twenty-four cul-
tures were obtained for the monolayer cultures, 64 explants
were obtained for the explant cultures, 16 explants were
obtained for autoradiography, and 64 explants were
obtained for histology. Statistical analysis was performed
using Student’s t test. A P value less than 0.05 was con-
sidered statistically significant.
3 Results
3.1 [35S]-Sulphate incorporation in monolayer cultures
LIPUS treatment stimulated [35S]-sulphate incorporation in
both the degenerative and collateral monolayer cultures by
respectively 1.5-fold (P \ 0.05) and 1.2-fold (P \ 0.05)
(Fig. 1). Stimulation of [35S]-sulphate incorporation by
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LIPUS was 1.3-fold higher in the degenerative than in the
collateral monolayers (Fig. 1).
3.2 [35S]-Sulphate incorporation in explants
[35S]-Sulphate incorporation was 1.2-fold higher
(P = 0.043) in untreated degenerative explants in
comparison with untreated collateral explants (Fig. 2). [35S]-
Sulphate incorporation was also increased in the LIPUS-
treated degenerative explants compared to the LIPUS-trea-
ted collateral explants, but no statistical significance
(P = 0.073) was reached (Fig. 2). LIPUS treatment did not
result in changes in [35S]-sulphate incorporation in the
degenerative and collateral explants in comparison with the
untreated control cartilage explants (control collateral
8.6 ± 0.4 cpm 9 103/mg dry weight; LIPUS-treated col-
lateral 8.6 ± 0.5 cpm 9 103/mg dry weight; control
degenerative 10.7 ± 0.8 cpm 9 103/mg dry weight; LI-
PUS-treated degenerative 10.5 ± 0.9 cpm 9 103/mg dry
weight; values are mean ± SEM).
3.3 Autoradiography of explants
LIPUS resulted in a significant increase in the number of
dots per cell in its surrounding matrix by 1.9-fold in
degenerative cartilage explants compared to control carti-
lage explants (P = 0.03) (Fig. 3). In the collateral explants
a similar trend of a higher increase (1.3-fold) in the number
of dots per cell in its surrounding matrix in the LIPUS-
treated cartilage explants was found in comparison with the
untreated control cartilage explants (Fig. 3).
3.4 Histomorphometry of explants
Detailed photographs of the superficial and deep layer of an
explant treated with LIPUS and an untreated control
explant are shown in Fig. 4.
In the deep layer of the cartilage explants, LIPUS
treatment decreased the number of cell nests containing 1–
3 cells significantly in both the collateral explants by 1.5-
fold (P = 0.009) and in the degenerative explants by 1.6-
fold (P = 0.05) (Fig. 5). However, LIPUS treatment did
not decrease the number of cell nests containing 1–3 cells
in the superficial layer of the collateral explants nor of the
degenerative explants. In the superficial layer of the col-
lateral explants, LIPUS treatment significantly stimulated
the number of nests containing 4–6 cells by 6.5-fold
(P = 0.006) (Fig. 6). LIPUS treatment did not change the
number of nests containing 4–6 cells in the degenerative
explants in the superficial layer. In the deep layer, LIPUS
treatment stimulated the number of nests containing 4–6
cells significantly by 4.8-fold (P \ 0.001) in the collateral
Fig. 1 Effect of LIPUS on 35[S]-sulphate incorporation into glycos-
aminoglycans of degenerative and collateral human chondrocyte
monolayer cultures. Results are mean ± SEM of 24 chondrocyte
cultures obtained from 2 donors. T/C LIPUS-treated-over-control
ratio, COL chondrocytes obtained from the collateral compartment,
DEG chondrocytes obtained from the degenerative compartment, US
LIPUS treated, con untreated control. * Significant difference in
35[S]-sulphate incorporation (P \ 0.05)
Fig. 2 35[S]-Sulphate incorporation into glycosaminoglycans in
human cartilage explants of degenerative and collateral explants.
Results are mean ± SEM of 64 explants obtained from four donors.
COL explants obtained from the collateral compartment, DEG
explants obtained from the degenerative compartment, US LIPUS
treated, con untreated control. # Significant difference in 35[S]-
sulphate incorporation between untreated degenerative explants and
untreated collateral explants (P = 0.043)
Fig. 3 Effect of LIPUS on 35[S]-sulphate into glycosaminoglycans in
human cartilage explants of degenerative and collateral explants
analysed by autoradiography. Results are mean ± SEM dots per cell
of 16 explants obtained from one donor. COL explants obtained from
the collateral compartment, DEG explants obtained from the degen-
erative compartment, US LIPUS treated, con untreated control.
* Significant effect of LIPUS in degenerative explants (P = 0.03)
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explants and by 3.9-fold in the degenerative explants
(P \ 0.001) (Fig. 6).
4 Discussion
In this study, we have investigated the effect of low-
intensity pulsed ultrasound (LIPUS) on human chondrocyte
proliferation and cartilage matrix production in vitro. We
hypothesized that LIPUS stimulates both chondrocyte
proliferation and matrix production in human degenerative
and collateral cartilage explants as well as in cultures of
isolated human chondrocytes. We are aware that that not
only the degenerative compartment but also the collateral
Fig. 4 Histology of human
cartilage explants obtained from
the collateral compartment.
Details of the superficial layer
(a) and deep layer (b) of
untreated control cartilage
explants, and of the superficial
layer (c) and deep layer (d) of
LIPUS treated cartilage
explants. In the deep layer the




Fig. 5 Effect of LIPUS on number of cell-nests in the superficial
layer (closest to the joint) and the deep layer (closest to the bone) in
human degenerative and collateral cartilage explants. Results are
mean ± SEM of the number of cell nests with 1–3 cells-per-nest of
64 explants obtained from four donors. COL explants obtained from
the collateral compartment, DEG explants obtained from the degen-
erative compartment; con untreated control, US LIPUS treated.
* Significant effect of LIPUS in the deep layer of degenerative
(P = 0.05) and collateral (P = 0.009) explants
Fig. 6 Effect of LIPUS on number of cell-nests in the superficial
layer (closest to the joint) and the deep layer (closest to the bone) in
human degenerative and collateral cartilage explants. Results are
mean ± SEM of the number of cell nests with 4–6 cells-per-nest of
64 explants obtained from four donors. COL explants obtained from
the collateral compartment, DEG explants obtained from the degen-
erative compartment, con untreated control, US LIPUS treated.
* Significant effect of LIPUS in the superficial layer collateral
explants (P = 0.006). * Significant effect of LIPUS in the deep layer
of degenerative and collateral explants (P \ 0.001)
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compartment of the degenerative joint might be involved in
the degenerative process. Surgeons have diagnosed uni-
compartimental OA of the knee in the donors, according to
general accepted criteria [7]. The severity of the symptoms
determines the need for treatment at the degenerative site
[7]. The biopsy in the collateral compartment was taken
where the cartilage appeared intact. We found differences
in chondrocyte proliferation and matrix production after
LIPUS stimulation in the degenerative and collateral
compartments. This gives us reliance that our study design
is appropriate to investigate whether LIPUS exerts an
anabolic effect on human osteoarthritic or non-osteoarthritc
(or less osteoarthritic) chondrocyte proliferation and carti-
lage matrix production.
We were able to harvest sufficient cartilage from two
donors in order to establish monolayer cultures. The
amount of cartilage that could be harvested from the other
donors was too limited to establish monolayer cultures.
A sufficient amount of cartilage explants could be obtained
from four donors. The data suggest that LIPUS stimulates
cartilage matrix production in both degenerative and col-
lateral monolayer cultures and human explants and
stimulates chondrocyte proliferation in both degenerative
and collateral human explants. This is in agreement with
chondrogenic stimulatory effects found by LIPUS treat-
ment in chick embryos, rats and rabbits [2, 16, 17, 20, 21].
In chondrocyte monolayer cultures a significant stimu-
latory effect of LIPUS treatment on [35S]-sulphate
incorporation was observed, especially in degenerative
chondrocytes. [35S]-Sulphate incorporation was signifi-
cantly increased in degenerative explants compared to
collateral explants for the untreated control explants.
LIPUS-treated explants showed comparable increase in
sulphate incorporation in the degenerative explants com-
pared to the collateral explants, but reached no statistical
significance. LIPUS did not result in overall significant
changes in [35S]-sulphate incorporation compared to the
untreated control explants in neither degenerative explants
nor collateral explants using biochemical analysis sug-
gesting that LIPUS did not affect matrix turnover.
However, increased [35S]-sulphate incorporation in LIPUS-
treated degenerative explants of one donor was seen,
indicating a stimulation of matrix production resulting
from LIPUS treatment in the explants of this single donor.
This suggests differences between cartilage obtained from
one donor and cartilage obtained from another donor. This
finding is comparable to the results obtained by Kopakkala-
Tani et al. [9] who found that chondrocytes obtained from
one donor out of five donors remained non-responsive to
ultrasound treatment. Several studies have addressed the
role of LIPUS as a stimulus for aggrecan synthesis in
relation to chondrogenesis [4, 16, 20, 21]. LIPUS stimu-
lated aggrecan mRNA expression and proteoglycan
synthesis in rat chondrocytes, and in a rat femur fracture
model LIPUS increased mechanical properties of the
healing fracture by accelerating synthesis of extra cellular
matrix proteins [16, 20]. Our finding that LIPUS stimulates
matrix production in articular cartilage monolayer cultures
is in agreement with these studies. In addition, TGF-b
treatment of mesenchymal stem cells has been shown to
enhance chondrogenic differentiation, which is related to
an increase in aggrecan deposition [4]. Application of LI-
PUS for 20 min per day to the TGF-b treated mesenchymal
stem cells even further increased aggregan deposition [4].
LIPUS enhanced chondrogenic differentiation, but not cell
proliferation [4]. In an aggregate chondrocyte culture sys-
tem LIPUS promotes proliferation, and retains the
differentiation state of chondrocytes [12]. The effect of
LIPUS on proliferation and differentiation was found to be
mediated by TGF-b [12].
Different types of cartilage, i.e. hyaline cartilage and
endochondral cartilage, which transforms into bone, show
different reactions to LIPUS stimulation [21]. LIPUS
enhances bone formation by stimulating hypertrophy of
chondrocytes directed to terminal differentiation, but it
does not induce hypertrophy of chondrocytes in hyaline
cartilage [21]. LIPUS stimulation does not affect tissue
maturation in mice with hyaline-like cartilage implants
(generated in vitro) implanted subcutaneously in the back,
suggesting that LIPUS treatment does not accelerate mat-
uration of tissue-engineered neo-cartilage [3].
Although the number per group for the autoradiography
experiment was low (n = 4 per group), we found an effect
size of d [ 2 [1]. This means that the power is much higher
than 60% and that the findings are of importance. Our
observation of increased [35S]-sulphate incorporation in
proteoglycans by autoradiography suggests a stimulatory
effect of LIPUS on chondrogenesis. In degenerative explants
increased proteoglycan synthesis was found compared to
collateral explants, suggesting a stimulation of cartilage
matrix production by individual cells. These results are in
agreement with reported effects of LIPUS on hyaline carti-
lage in the distal part of the sternum of chick embryos [21].
The sternum of chick embryos is characterized by a proximal
part that shows endochondral ossification and a hyaline distal
part that does not calcify. In the proximal part LIPUS may
augment bone formation by stimulating hypertrophy of
chondrocytes that are developing toward terminal differen-
tiation; in the distal part LIPUS induces increased type II
collagen and aggrecan production, indicating a potential role
in cartilage repair [21].
Histomorphometric analysis showed that LIPUS stimu-
lation significantly decreased the number of nests with a
low number of chondrocytes (1–3 cells per nest) for the
degenerative and for the collateral explants in the deep
cartilage layer. The number of cell nests with high
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chondrocyte numbers (4–6 cells per nest) was strongly
increased in the degenerative and in the collateral explants
in the deep cartilage layer, suggesting that LIPUS stimu-
lates chondrocyte proliferation in the deep layer of
cartilage. Since the stimulation of cell nests with high
chondrocyte numbers (4–6), the number of nests with low
numbers of chondrocytes (1–3) was significantly reduced.
These findings are interesting since cellular differences
might underlie differences in cartilage quality. LIPUS
evidently stimulates chondrocyte proliferation in the deep
cartilage layer of human explants, layer closest to the bone,
which normally contains less cells than the superficial
layer, layer closest to the joint. The effects of LIPUS
treatment on the number of cells in a cell nest are seen in
degenerative cartilage as well as in collateral cartilage.
LIPUS-treated chondrocytes in hyaline cartilage of the
distal part of the sternum of chick embryos has been shown
an intensity dependent proliferation and a decreased
hypertrophic differentiation, which may influence the res-
toration and repair of articular cartilage [22]. However,
Nishikori et al. [13] found that LIPUS treated in gel
embedded chondrocytes of articular cartilage of 10 week
old rabbits did not show stimulated cell proliferation, but
an increase in chondroitin sulphate synthesis. Since we
studied cartilage explants instead of gel embedded chon-
drocytes, our results, indicating an increase in number of
cell nests and cell-nest-size in human chondrocytes, are not
in agreement with the observations Nishikori et al. [13].
In conclusion, the present study suggests that LIPUS
stimulates chondrocyte proliferation and matrix production
in cartilage obtained from the degenerative compartment
and to a limited degree in cartilage obtained from the
collateral compartment. Since LIPUS stimulated both
chondrocyte proliferation and matrix production by chon-
drocytes of articular human cartilage in vitro, it might
provide a feasible tool for cartilage tissue repair in osteo-
arthritic patients.
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